Yatrik M Shah Selected Research

Anti-Bacterial Agents (Antibiotics)

4/2019	Neutrophils Restrict Tumor-Associated Microbiota to Reduce Growth and Invasion of Colon Tumors in Mice.
6/2012	Pregnane X receptor as a target for treatment of inflammatory bowel disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yatrik M Shah Research Topics

Disease

53	Hypoxia (Hypoxemia) 05/2024 - 06/2008
40	Neoplasms (Cancer) 01/2024 - 08/2005
21	Inflammation (Inflammations) 01/2024 - 02/2008
16	Colitis 01/2024 - 02/2007
14	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 05/2012
13	Carcinogenesis 12/2023 - 06/2007
11	Colonic Neoplasms (Colon Cancer) 11/2023 - 05/2012
9	Iron Overload 11/2023 - 06/2013
8	Iron Deficiencies 01/2024 - 02/2009
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 02/2007
7	Insulin Resistance 05/2018 - 11/2007
6	Anemia 01/2024 - 12/2013
6	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2004
6	Obesity 01/2022 - 10/2011
4	Ulcerative Colitis 01/2024 - 02/2008
4	Body Weight (Weight, Body) 11/2023 - 02/2007
4	Adenocarcinoma 11/2022 - 04/2004
4	Fibrosis (Cirrhosis) 10/2021 - 08/2011
4	Fatty Liver 01/2018 - 08/2011
4	Necrosis 09/2014 - 11/2007
3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 11/2021
3	Colitis-Associated Neoplasms 02/2024 - 11/2017
3	Lung Injury 04/2023 - 12/2019
3	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2022 - 01/2019
3	Adenoma (Adenomas) 01/2022 - 01/2018
3	Hepatocellular Carcinoma (Hepatoma) 04/2016 - 12/2010
3	Thalassemia 01/2016 - 03/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2014 - 01/2012
3	Hemorrhage 04/2011 - 02/2007
3	Diarrhea 10/2010 - 02/2007
3	Endometrial Neoplasms (Endometrial Cancer) 08/2005 - 04/2004
2	Crohn Disease (Crohn's Disease) 01/2024 - 10/2010
2	Brain Neoplasms (Brain Tumor) 10/2023 - 04/2023
2	Dysbiosis 01/2023 - 01/2022
2	Intestinal Diseases (Diseases, Intestinal) 01/2023 - 01/2023
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2023 - 01/2013
2	Weight Loss (Weight Reduction) 01/2022 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2013
2	Hemochromatosis (Bronze Diabetes) 01/2022 - 01/2016
2	Liver Diseases (Liver Disease) 10/2021 - 01/2018
2	Acute Liver Failure (Fulminant Hepatic Failure) 10/2021 - 07/2012
2	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

34	IronIBA 04/2024 - 02/2009
25	Transcription Factors (Transcription Factor)IBA 05/2024 - 02/2007
18	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2004
16	Oxygen (Dioxygen)IBA 05/2024 - 08/2011
10	CytokinesIBA 11/2023 - 02/2007
9	Dextran SulfateIBA 01/2024 - 02/2008
7	HepcidinsIBA 01/2024 - 03/2012
6	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 11/2017
6	LipidsIBA 03/2024 - 08/2011
6	Fatty Acids (Saturated Fatty Acids)IBA 11/2022 - 04/2008
6	Messenger RNA (mRNA)IBA 12/2017 - 11/2006
6	pirinixic acidIBA 04/2016 - 06/2007
5	CateninsIBA 01/2024 - 05/2014
5	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 02/2012
5	Tamoxifen FDA LinkGeneric 11/2020 - 04/2004
5	Insulin (Novolin)FDA Link 01/2018 - 11/2007
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2016 - 11/2007
4	Dextrans (Dextran)FDA Link 02/2024 - 09/2014
4	Mechanistic Target of Rapamycin Complex 1IBA 01/2023 - 02/2016
4	NF-kappa B (NF-kB)IBA 05/2022 - 04/2007
4	Estrogen ReceptorsIBA 01/2022 - 04/2004
4	ChromatinIBA 01/2021 - 08/2011
4	RNA (Ribonucleic Acid)IBA 04/2019 - 01/2017
4	LigandsIBA 01/2019 - 11/2006
4	LuciferasesIBA 01/2018 - 10/2013
4	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 02/2016 - 06/2008
4	Von Hippel-Lindau Tumor Suppressor ProteinIBA 01/2013 - 06/2008
3	AzoxymethaneIBA 02/2024 - 05/2014
3	Dietary IronIBA 01/2024 - 06/2013
3	SeleniumIBA 12/2023 - 08/2005
3	Phosphotransferases (Kinase)IBA 01/2023 - 01/2018
3	Estrogens (Estrogen)FDA Link 01/2022 - 03/2005
3	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2021 - 04/2009
3	Bile Acids and Salts (Bile Acids)IBA 09/2014 - 07/2013
3	Triglycerides (Triacylglycerol)IBA 01/2013 - 06/2007
3	Rifaximin (L 105)FDA Link 06/2012 - 07/2007
3	PPAR alphaIBA 03/2010 - 06/2007
3	Estradiol (Delestrogen)FDA LinkGeneric 11/2006 - 04/2004
3	Estrogen Receptor alphaIBA 11/2006 - 08/2005
2	NAD (NADH)IBA 03/2024 - 03/2023
2	sulfide quinone reductaseIBA 03/2024 - 03/2023
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2024 - 01/2017
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2024 - 01/2019
2	TankyrasesIBA 12/2023 - 01/2023
2	metal transporting protein 1 (ferroportin)IBA 11/2023 - 06/2011
2	Guanosine Triphosphate (GTP)IBA 10/2023 - 04/2023
2	AcidsIBA 04/2023 - 12/2019
2	AmmoniaIBA 01/2023 - 01/2021
2	Amino Acids FDA Link 01/2023 - 11/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2021
2	NexusIBA 01/2023 - 01/2023
2	Chelating AgentsIBA 01/2023 - 01/2016
2	Ferritins (Ferritin)IBA 01/2023 - 01/2020
2	3-hydroxypropionaldehydeIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2014
2	CalciumIBA 01/2021 - 01/2018

Therapy/Procedure

16	Therapeutics 01/2024 - 04/2004
2	Gastrectomy 01/2022 - 01/2022